[go: up one dir, main page]

KR920003992A - Mixed vaccine for simultaneous prevention of whooping cough, diphtheria, tetanus and hepatitis B - Google Patents

Mixed vaccine for simultaneous prevention of whooping cough, diphtheria, tetanus and hepatitis B Download PDF

Info

Publication number
KR920003992A
KR920003992A KR1019900013356A KR900013356A KR920003992A KR 920003992 A KR920003992 A KR 920003992A KR 1019900013356 A KR1019900013356 A KR 1019900013356A KR 900013356 A KR900013356 A KR 900013356A KR 920003992 A KR920003992 A KR 920003992A
Authority
KR
South Korea
Prior art keywords
hepatitis
antigen
diphtheria
vaccine
tetanus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019900013356A
Other languages
Korean (ko)
Other versions
KR920009729B1 (en
Inventor
김이섭
정동혁
Original Assignee
허영섭
주식회사 녹십자
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 허영섭, 주식회사 녹십자 filed Critical 허영섭
Priority to KR1019900013356A priority Critical patent/KR920009729B1/en
Publication of KR920003992A publication Critical patent/KR920003992A/en
Application granted granted Critical
Publication of KR920009729B1 publication Critical patent/KR920009729B1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

내용 없음.No content.

Description

백일해, 디프테리아, 파상풍 및 B형 간염의 동시 예방을 위한 혼합백신Mixed vaccine for simultaneous prevention of whooping cough, diphtheria, tetanus and hepatitis B

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (6)

백일해, 디프테리아, 파상풍 및 B형 간염을 동시에 예방할 수 있는 혼합백신.A combination vaccine that can simultaneously prevent pertussis, diphtheria, tetanus, and hepatitis B. 제1항에 있어서, 백일해의 항원이 정제 백일해 방어 항원임을 특징인 혼합백신.The combination vaccine according to claim 1, wherein the antigen of whooping cough is a purified whooping cough defense antigen. 제1항에 있어서, B형 간염항원이 혈장에서 분리하거나, 유전공학적으로 제조한 B형 간염 표면항원인 혼합백신.2. The combination vaccine of claim 1, wherein the hepatitis B antigen is a hepatitis B surface antigen isolated from plasma or genetically engineered. 제1항에 있어서, 흡착제가 수산화 알루미늄 겔인 혼합백신.The combined vaccine of claim 1, wherein the adsorbent is aluminum hydroxide gel. 제1항에 있어서, B형 간염 표면항원의 조성량이 1회 투여량중 5∼20㎍임이 특징한 혼합백신.The mixed vaccine according to claim 1, wherein the composition of hepatitis B surface antigen is 5 to 20 µg in a single dose. 정제 백일해 방어항원 원액에 정제 HBsAg 원액을 혼합하고, 포르마린 처리하여 HBsAg가 정제 백일해 방어항원에 흡착시킴과 동시에 공지의 방법에 따라 디프테리아, 파상풍 톡소이드를 알루미늄 겔에 흡착시킨 것을 배합시킴을 특징으로 하는 혼합백신의 제조방법.The purified HBsAg stock solution is mixed with the purified pertussis anti-antigen stock solution, followed by formarin treatment to adsorb HBsAg to the purified pertussis anti-antigen, and to adsorb diphtheria and tetanus toxoid on aluminum gel according to a known method. Method of Making Vaccine. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019900013356A 1990-08-29 1990-08-29 Mixed vaccine of d.p.t. and hepatitis b Expired KR920009729B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019900013356A KR920009729B1 (en) 1990-08-29 1990-08-29 Mixed vaccine of d.p.t. and hepatitis b

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019900013356A KR920009729B1 (en) 1990-08-29 1990-08-29 Mixed vaccine of d.p.t. and hepatitis b

Publications (2)

Publication Number Publication Date
KR920003992A true KR920003992A (en) 1992-03-27
KR920009729B1 KR920009729B1 (en) 1992-10-22

Family

ID=19302836

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900013356A Expired KR920009729B1 (en) 1990-08-29 1990-08-29 Mixed vaccine of d.p.t. and hepatitis b

Country Status (1)

Country Link
KR (1) KR920009729B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017048038A1 (en) * 2015-09-16 2017-03-23 Lg Life Sciences Ltd. Combination vaccine composition for multiple-dosage

Also Published As

Publication number Publication date
KR920009729B1 (en) 1992-10-22

Similar Documents

Publication Publication Date Title
UA40596C2 (en) VACCINE COMPOSITION AND METHOD OF PREPARATION
PE11298A1 (en) Vaccines
UA39174C2 (en) associates of deprotonic hyaluronic acid, method for preparation of associates of deprotonic hyaluronic acid, pharmaceutical composition and method for preparation of pharmaceutical composition
EA200201240A1 (en) POLYVALENT VACCINE COMPOSITION
DE69327534D1 (en) VACCINE AGAINST DIPHTHERIETOXIN
MY141594A (en) 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
NL300401I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
BG103141A (en) Composition of a malaria vaccine
BRPI9712917B8 (en) vaccine composition comprising diphtheria, tetanus and pertussis toxoids.
KR960700746A (en) Treatment of H. PYLORI ASSOCIATED GASTRODUODENAL DISEASE
ES2140652T3 (en) USE OF N-ALKYL-DERIVATIVES OF 1,5-DIDESOXI-1,5-IMINO-D-GLUCITOL FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS.
HUT63770A (en) Conjugated vaccine against microorganisms belonging to streptococcus 8 group
ES2126616T3 (en) COMBINED PEDIATRIC VACCINE, WITH INCREASED IMMUNOGENICITY OF EACH COMPONENT OF THE VACCINE.
KR920003992A (en) Mixed vaccine for simultaneous prevention of whooping cough, diphtheria, tetanus and hepatitis B
HU9301797D0 (en) Utilization of il-4 for producing pharmaceutical preparatives improving immunoreaction
KR850006138A (en) Method for preparing flavone-rich chamomile extract
KR910009267A (en) How to Treat Depression
KR920017668A (en) Methods for inhibiting or preventing cancer metastasis and preparations therefor
DE59003060D1 (en) Pharmaceutical preparation containing protein S.
ATE207357T1 (en) USE OF COTININE TO RELIEF TOBACCO WITHDRAWAL SYNDROME
KR850001696A (en) Induction of adjuvant response or immune response in warm-blooded animals
KR830005360A (en) How to prepare chizanimicin
GB949399A (en) Poliomyelitis vaccines
IT1176630B (en) NATURAL CHELATES FOR THE SEPARATION OF RADIONUCLIDES
ATE177010T1 (en) IMMUNE BOOSTING OF VACCINES, ESPECIALLY VACCINES AGAINST SWINE PLEUROPNEUMONIA

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19900829

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19900829

Comment text: Request for Examination of Application

PG1501 Laying open of application
G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19920930

O035 Opposition [patent]: request for opposition
PO0301 Opposition

Comment text: Request for Opposition

Patent event code: PO03011R01D

Patent event date: 19921219

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19930813

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19930813

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19950119

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19960129

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19970307

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19980907

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19990826

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20000930

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20011023

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20021023

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20031023

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20041025

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20051012

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20061019

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20070824

Start annual number: 16

End annual number: 16

PR1001 Payment of annual fee

Payment date: 20081022

Start annual number: 17

End annual number: 17

FPAY Annual fee payment

Payment date: 20091022

Year of fee payment: 18

PR1001 Payment of annual fee

Payment date: 20091022

Start annual number: 18

End annual number: 18

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20110509

Termination category: Expiration of duration